杏百二三汤加减治疗慢性阻塞性肺病急性期痰浊阻肺证临床观察

Clinical Observation on Modified XingBai ErSan Tangin the Treatment of Chronic Obstructive Pulmonary Disease at Acute Stage of Phlegm-turbidity Obstructing Lung Pattern

目的:观察杏百二三汤加减治疗慢性阻塞性肺病(COPD)急性期痰浊阻肺证的疗效。方法:将COPD急性期痰浊阻肺证患者70例随机分为2组,对照组35例予吸氧抗感染"平喘"补液等西医常规治疗;治疗组35例在对照组治疗的基础上予杏百二三汤加减口服治疗,7天为1个疗程,2个疗程后观察疗效。结果:2组有效率比较有显著性差异(P<0.05),治疗组疗效优于对照组。结论:杏百二三汤加减治疗COPD急性期痰浊阻肺证疗效显著。

Objective： To survey clinical effects of modified XingBai ErSan Tang in treating chronic obstructive pulmonary disease （COPD） at acute stage of phlegm-turbidity obstructing lung pattern. Methods： Seventy patients were randomized into two group, the control group were given routine treatment of western medicine including oxygen inhalation,anti-inflammation, relieving asthma and fluid infusions; the treatment group took modified XingBai ErSan Tang orally on the foundation of the therapy the control group received, seven days were one course of the treatment, clinical effects were observed after two courses of the treatment. Results： There was significant difference in the comparison of effective rates between both groups （P〈0.05）, the treatment group was superior to the control group in curative effects. Conclusion： Modified XingBai ErSan Tang is effective in treating COPD at acute stage of phlegm-turbidity obstructing lung pattern.